Skip to main content
. 2006 Jan 31;10(1):R20. doi: 10.1186/cc3984

Table 2.

Terlipressin (TP) treatment and outcome

Patient Time from PICU admission to TP therapy (hours) Time of maintenance of TP therapy (hours) Adverse effectsa PICU length of stay (days) Survival of episode Cause of death Sequela
1 40 48 No 49 Yes Minor amputation (one right hand finger)
2 4 32 Ischemia (limited to toes) 7 Yes No
3 12 65 No 51 No Refractory shock
4 6 3 Severe limbs and cutaneous ischemia, hyperkalemia 6 No Ventricular fibrillation
5 24 24 Limbs and cutaneous ischemia 22 Yes Major amputation: lower limbs (below knees) and both hands
6 72 102 No 49 Yes Minor amputation (one hand finger)
7 26 8 Severe limbs ischemia, cutaneous ischemia, hyperbilirubinemia 14 No Withdraw of therapy
8 48 20 Rabdomyolisis? 22 Yes No
9 4 5 Oliguria 9 Yes Partial anopsy, dismetry
10 32 96 Cutaneous and intestinal ischemia 6 No Withdraw of therapy
11 168 52 Limb and cutaneous ischemia, oliguria 8 No Multiorgan failure
12 14 7 No 1 No Arrhythmia
13 60 8 No 3 No Ventricular fibrillation
14 20 20 No 1 No Refractory shock
15 5 18 Limbs ischemia, rabdomyolisis 2 No Refractory shock
16 48 72 Limbs and cutaneous ischemia 14 Yes

PICU, pediatric intensive care unit. aBased in the opinion of the responsible physician